CVRx offers a heart failure therapy option with Barostim™, the world’s first neuromodulation device for heart failure management. Learn more now!

The Barostim System Baroreflex Activation Therapy is delivered by the Barostim NEO2, an implantable pulse generator (IPG) designed to deliver continuous electrical stimulation to carotid baroreceptors. …

Barostim™ is a heart failure breakthrough therapy option that is a safe procedure. Learn more to see if Barostim may be right for you.

Have questions about CVRx or Barostim? CVRx provides answers to the top frequently asked questions. Get the answers to your questions today.

Barostim Barostim™ is a novel implantable device for treating Heart Failure with reduced ejection fraction, also known as systolic heart failure. Barostim stimulates baroreceptors, natural sensors in …

Barostim complements neurohormonal blockade by working earlier in the same pathway5 Barostim works by electrically stimulating carotid baroreceptors which increases baroreceptor signaling, …

The Barostim System is indicated for patients who are NYHA Class III or Class II (who had a recent history of Class III) despite treatment with guideline-directed medical therapies (medications and …

Bilateral carotid bifurcations above mandible level Baroreflex failure or autonomic neuropathy Uncontrolled, symptomatic cardiac bradyarrhythmias > 50% carotid atherosclerosis

Our life goal at CVRx® is to make yours better. CVRx® advances healthcare for people everywhere, giving each patient a fuller life. Learn about CVRx® today!

Barostim is not right for everyone. Your doctor can share information about whether Barostim might be an option for you, as well as about the risks, benefits, and likely outcomes of Barostim therapy. It is …